NEW YORK— Medical device maker Abbott Laboratories said Thursday it has agreed to buy replacement heart valve maker Tendyne Holdings for $225 million, and has invested in a second company in the field. Tendyne is conducting a U.S. clinical trial of a product called the bioprosthetic mitral valve system and it plans to start a study in 2016 to support approval of...» Read More
Feb 17- Medical device maker Medtronic Plc reported a 28 percent rise quarterly profit, helped mainly by increased sales in its cardiac and vascular business, its largest. The company, which completed its acquisition of Ireland- based Covidien Plc in January, said its net profit rose to $977 million, or 98 cents per share, for the third quarter ended Jan. 23, from $762...
*4th- qtr adj/shr $0.22 vs est $0.21. Feb 4- Boston Scientific Corp's adjusted quarterly profit edged past the average analyst estimate and the medical device maker reported a growth in sales for the fifth straight quarter, helped by continued demand for its heart devices. Boston Scientific's sales growth and improving margin have been encouraging in the...
Feb 4- Medical device maker Boston Scientific Corp posted a 19 percent fall in fourth-quarter profit as litigation charges more than doubled. Boston Scientific, along with Johnson& Johnson, awaits a New York federal court decision in what could culminate into the final leg of a more than eight-year battle between the two. J&J is seeking more than $7.2 billion in...
Feb 4- Medical device maker Boston Scientific Corp posted a 19 percent fall in fourth-quarter profit as litigation charges more than doubled. The company's net income fell to $87 million, or 6 cents per share, in the quarter ended Dec. 31 from $108 million, or 8 cents per share, a year earlier. Excluding charges for restructuring, litigation and other costs, the...
CNBC Crowdfinance Tech Index lists the largest capital commitments raised by 25 private U.S. tech companies on Crowdnetic’s data platform.
Dan Mahony, fund manager at Polar Capital, tells CNBC how to be a "smart healthcare investor".
George Freeman MP, minister of life sciences in the U.K., says there's been a "resurgence" for life sciences and healthcare investment.
How much would it cost world governments to insulate their economies from global pandemics. Would you believe nearly $344 billion?
A flu shot that lasts 10 years could be a reality soon, a top hospital executive told CNBC, along with "real steps" toward a cancer vaccine.
Analysts are expecting a jump in earnings growth from the healthcare sector, but will its success continue into 2015? Andrew Burkly, managing director and head of institutional portfolio strategy at Oppenheimer Asset Management, shares his thoughts.
Despite the endless controversies dogging Obamacare, the CEO of Mount Sinai believes the legislation is meeting many of its goals.
The first trial of an Ebola vaccine has started with the vaccination of three health care workers in Mali, researchers told NBC News.
Another day, another new wrist-wearable in gadgetland. But this one sounds … pretty compelling. Re/code explains.
The death toll from the Ebola virus in West Africa keeps growing to record levels. And ironically, that may be why there's no vaccine, said an expert.
A David taking on retail Golaiths, this e-commerce upstart is circumventing traditional channels and selling eyeglasses to the masses.
One of the world's largest makers of medical devices, Medtronic, is considering a takeover of London-based Smith & Nephew, Bloomberg said.
As AstraZeneca's shares slid following its rejection of Pfizer's new bid, the company's chairman said he was "reasonably confident" it was the right decision.
Boston Scientific received a subpoena this week from the Department of Health and Human Services seeking information about its defibrillators.
Johnson & Johnson turned in a solid first quarter Tuesday, topping analysts' profit and revenue estimates and increasing its 2014 earnings forecast by 5 cents a share.
The Gates Foundation has awarded $2 million in grants to several Indian organizations to help improve sanitation by building a high-tech toilet.